Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial.

Schytte T, Knap MM, Kristiansen C, Appelt AL, Khalil A, Peucelle C, Lutz CM, Møller DS, Sande EPS, Sundby F, Persson G, Schmidt H, Land LH, Rogg L, Pøhl M, Lund MD, Nielsen M, Levin N, Hansen O, Thing RS, Borissova S, Halvorsen T, Nielsen TB, Hansen TS, Haakensen VD, Ottosson W, Brink C, Hoffmann L

Open source

DOI: 10.1200/jco-24-01386
Published: 2025 Jun 10
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-24-01386,
  title = {Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial.},
  author = {Schytte T and Knap MM and Kristiansen C and Appelt AL and Khalil A and Peucelle C and Lutz CM and Møller DS and Sande EPS and Sundby F and Persson G and Schmidt H and Land LH and Rogg L and Pøhl M and Lund MD and Nielsen M and Levin N and Hansen O and Thing RS and Borissova S and Halvorsen T and Nielsen TB and Hansen TS and Haakensen VD and Ottosson W and Brink C and Hoffmann L},
  year = {2025},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-24-01386},
  url = {https://doi.org/10.1200/jco-24-01386}
}

RIS

TY  - JOUR
TI  - Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial.
AU  - Schytte T
AU  - Knap MM
AU  - Kristiansen C
AU  - Appelt AL
AU  - Khalil A
AU  - Peucelle C
AU  - Lutz CM
AU  - Møller DS
AU  - Sande EPS
AU  - Sundby F
AU  - Persson G
AU  - Schmidt H
AU  - Land LH
AU  - Rogg L
AU  - Pøhl M
AU  - Lund MD
AU  - Nielsen M
AU  - Levin N
AU  - Hansen O
AU  - Thing RS
AU  - Borissova S
AU  - Halvorsen T
AU  - Nielsen TB
AU  - Hansen TS
AU  - Haakensen VD
AU  - Ottosson W
AU  - Brink C
AU  - Hoffmann L
PY  - 2025
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-24-01386
UR  - https://doi.org/10.1200/jco-24-01386
ER  -

APA

T, S., MM, K., C, K., AL, A., A, K., C, P., CM, L., DS, M., EPS, S., F, S., G, P., H, S., LH, L., L, R., M, P., MD, L., M, N., N, L., O, H., RS, T., S, B., T, H., TB, N., TS, H., VD, H., W, O., C, B., & L, H. (2025). Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-24-01386

Source records

pubmed · retrieved 2026-09-27T09:41:11.445Z